ARADIGM
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.
ARADIGM
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1991-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.aradigm.com
Total Employee:
11+
Status:
Closed
Contact:
(510)265-9000
Email Addresses:
[email protected]
Total Funding:
75.51 M USD
Technology used in webpage:
Domain Not Resolving Canadian Server Location Microsoft Word
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Ockham Biotech
Ockham Biotech is a research company which is focussed on the development of inhaled heparin for the treatment of airway diseases
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Castle Creek Partners
Castle Creek Partners investment in Post-IPO Debt - Aradigm
Domain Associates
Domain Associates investment in Post-IPO Debt - Aradigm
Camden Partners
Camden Partners investment in Post-IPO Debt - Aradigm
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Debt - Aradigm
Official Site Inspections
http://www.aradigm.com Semrush global rank: 12.33 M Semrush visits lastest month: 115
- Host name: hostedc45.carrierzone.com
- IP address: 216.55.149.9
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aradigm"
Aradigm - Crunchbase Company Profile & Funding
Business Wire — Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2017 on February 13 . View All . Find More Contacts for Aradigm. …See details»
Anadigm®, The dpASP company
Anadigm has released for sale two new Development boards. Supporting two and four AN231E04 FPAA's respectively, the board have new faster USB connection to a PC and support larger …See details»
Aradigm Corporation - Products, Competitors, Financials, …
Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease. Use …See details»
Aradigm 2025 Company Profile: Valuation, Funding & Investors
Aradigm General Information Description. Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the …See details»
Aradigm - Products, Competitors, Financials, Employees, …
Headquarters Location. 26219 Eden Landing Road . Hayward, California, 94545, United States (510)783-0100See details»
Aradigm Corp (ARDM) Profile - The Globe and Mail
See the company profile for Aradigm Corp (ARDM) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Aradigm Company Profile - Office Locations, Competitors ... - Craft
See insights on Aradigm including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Aradigm - Company Profile - Tracxn
Mar 5, 2025 Developer of inhalable therapies for respiratory diseases. The company is developing Pulmaquin (an investigational proprietary formulation of ciprofloxacin for inhalation) …See details»
Aradigm Corporation - VentureRadar
Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of inhalation-based drug delivery technologies for... ... Find out ...See details»
Aradigm - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dec 22, 2024 Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.See details»
Aradigm - Contacts, Employees, Board Members, Advisors & Alumni
Experience the new Crunchbase, powered by AI . Organization. AradigmSee details»
Aradigm CEO and key executive team | Craft.co
Aradigm's President & Chief Executive Officer is Igor Gonda. Other executives include Nancy Pecota, CFO; Juergen Froehlich, Chief Medical Officer and 1 others. See the full leadership …See details»
Press Release - anadigm.com
Anadigm Inc. +1 480-422-0191 (voice) [email protected]. ... This New organization and webpage presentation for Application Notes, Design Notes, Training and presentation …See details»
Aradigm Announces Plans for Reorganization Under Chapter 11 of …
Feb 16, 2019 Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda CoSee details»
Aradigm Corporation | Insights
May 6, 2022 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Anadigm - Crunchbase Company Profile & Funding
Anadigm's FPAA devices are statically reconfigurable analog ICs that can be programmed to perform various analog functions using a predefined configuration bitstream. …See details»
Working at Aradigm Corporation: 2 Reviews - Indeed
Reviews from Aradigm Corporation employees about Aradigm Corporation culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Aradigm Corp. - The New York Times
Patents; A new technology allows pain medication to be inhaled for easier administration. Aradigm Corp patents technology it says will make pain medication much easier to administer; has …See details»
End of the line looms for Aradigm as it files for bankruptcy
Feb 19, 2019 A year after a major knockback from the FDA for its lead inhaled antibiotic product and protracted efforts to try to resurrect the program, Aradigm has filed for bankruptcy.See details»
Aradigm Announces Sale of Assets to Grifols, S.A.
Apr 3, 2020 Aradigm Corporation (OTC PINK: ARDM) (“Aradigm” or the “Company”) announced on March 30, 2020, the Bankruptcy Court entered an order approving the salSee details»